| Item Type | Name |
|
Concept
|
Adenine
|
|
Concept
|
Alkaloids
|
|
Concept
|
Adenosine
|
|
Concept
|
Aldehyde Reductase
|
|
Concept
|
Asparagine
|
|
Concept
|
Adenine Nucleotides
|
|
Concept
|
Antifungal Agents
|
|
Concept
|
Chromosome Banding
|
|
Concept
|
Chromosomes, Human, Pair 11
|
|
Concept
|
Chromosomes, Human, Pair 2
|
|
Concept
|
Chromosomes, Human, Pair 6
|
|
Concept
|
Analysis of Variance
|
|
Concept
|
Chromosomes, Human, Pair 8
|
|
Concept
|
Cytogenetics
|
|
Concept
|
Antigens, Differentiation, B-Lymphocyte
|
|
Concept
|
Cell Differentiation
|
|
Concept
|
Bone Marrow Examination
|
|
Concept
|
Borohydrides
|
|
Concept
|
Cattle
|
|
Concept
|
Boronic Acids
|
|
Concept
|
Bromodeoxyuridine
|
|
Concept
|
Chromosomes, Human, Pair 1
|
|
Concept
|
Chromosomes, Human, Pair 15
|
|
Concept
|
Chromosomes, Human, Pair 21
|
|
Concept
|
Chromosomes, Human, Pair 3
|
|
Concept
|
Chromosomes, Human, 4-5
|
|
Concept
|
Flavonoids
|
|
Concept
|
Chromosomes, Human, Pair 12
|
|
Concept
|
Chromosomes, Human, Pair 14
|
|
Concept
|
Chromosomes, Human, 6-12 and X
|
|
Concept
|
Chromosome Deletion
|
|
Concept
|
Chromosomes, Human, Pair 13
|
|
Concept
|
Chromosomes, Human, Pair 22
|
|
Concept
|
Chromosomes, Human, Pair 4
|
|
Concept
|
Codon
|
|
Concept
|
Burkitt Lymphoma
|
|
Concept
|
Chromosomes, Human, Pair 5
|
|
Concept
|
Chromosomes, Human, Pair 7
|
|
Concept
|
Chromosomes, Human, 13-15
|
|
Concept
|
C-Reactive Protein
|
|
Concept
|
Glucosephosphate Dehydrogenase
|
|
Concept
|
Chromosomes, Human, Pair 20
|
|
Concept
|
Chromosomes, Human, 16-18
|
|
Concept
|
Chromosomes, Human, 21-22 and Y
|
|
Concept
|
Hematopoiesis
|
|
Concept
|
Dimethyl Sulfoxide
|
|
Concept
|
Interleukin-2
|
|
Concept
|
Dogs
|
|
Concept
|
Echocardiography
|
|
Concept
|
Chromosomes, Human, Pair 17
|
|
Concept
|
Chromosomes, Human, Pair 9
|
|
Concept
|
Chromosomes, Human, 19-20
|
|
Concept
|
Exons
|
|
Concept
|
Family
|
|
Concept
|
Cost-Benefit Analysis
|
|
Concept
|
Emergency Medical Technicians
|
|
Concept
|
Harringtonines
|
|
Concept
|
Histocytochemistry
|
|
Concept
|
Erythropoiesis
|
|
Concept
|
Escherichia coli
|
|
Concept
|
Interleukin-1
|
|
Concept
|
Lepidoptera
|
|
Concept
|
Mice, Inbred C57BL
|
|
Concept
|
Mitoxantrone
|
|
Concept
|
Safety
|
|
Concept
|
Fetal Blood
|
|
Concept
|
Intestinal Absorption
|
|
Concept
|
Ribonucleoproteins
|
|
Concept
|
Humans
|
|
Concept
|
Styrenes
|
|
Concept
|
Tretinoin
|
|
Concept
|
Trisomy
|
|
Concept
|
Warfarin
|
|
Concept
|
Toxicology
|
|
Concept
|
CD56 Antigen
|
|
Concept
|
Vidarabine
|
|
Concept
|
Treatment Refusal
|
|
Concept
|
Drug Costs
|
|
Concept
|
Receptors, Granulocyte Colony-Stimulating Factor
|
|
Concept
|
Cost Savings
|
|
Concept
|
RNA-Binding Proteins
|
|
Concept
|
Antibodies, Bispecific
|
|
Concept
|
Health Care Costs
|
|
Concept
|
Mice, Knockout
|
|
Concept
|
Antigens, CD34
|
|
Concept
|
Telomerase
|
|
Concept
|
Antineoplastic Agents, Alkylating
|
|
Concept
|
Antigens, CD19
|
|
Concept
|
Staurosporine
|
|
Concept
|
Cross-Over Studies
|
|
Concept
|
Osteolysis
|
|
Concept
|
CpG Islands
|
|
Concept
|
Pentose Phosphate Pathway
|
|
Concept
|
Cladribine
|
|
Concept
|
Clonal Evolution
|
|
Concept
|
F-Box Proteins
|
|
Concept
|
Proto-Oncogene Proteins c-kit
|
|
Concept
|
Patient Participation
|
|
Concept
|
Antibiotic Prophylaxis
|
|
Concept
|
Styrene
|
|
Concept
|
Cyclin-Dependent Kinase Inhibitor p21
|
|
Concept
|
Mice
|
|
Concept
|
Core Binding Factors
|
|
Concept
|
Vincristine
|
|
Concept
|
Adaptor Proteins, Signal Transducing
|
|
Concept
|
Temperature
|
|
Concept
|
Multivariate Analysis
|
|
Concept
|
CD4-CD8 Ratio
|
|
Concept
|
Blood Component Transfusion
|
|
Concept
|
Vinblastine
|
|
Concept
|
Proto-Oncogene Proteins p21(ras)
|
|
Concept
|
GTP-Binding Proteins
|
|
Concept
|
Topotecan
|
|
Concept
|
Heterogeneous-Nuclear Ribonucleoprotein K
|
|
Concept
|
Pneumococcal Vaccines
|
|
Concept
|
Chromosome Disorders
|
|
Concept
|
Core Binding Factor Alpha 2 Subunit
|
|
Concept
|
STAT5 Transcription Factor
|
|
Concept
|
Heterogeneous-Nuclear Ribonucleoproteins
|
|
Concept
|
RNA-Binding Protein FUS
|
|
Concept
|
RNA, Small Interfering
|
|
Concept
|
Suppressor of Cytokine Signaling Proteins
|
|
Concept
|
Drug Discovery
|
|
Concept
|
Epigenomics
|
|
Concept
|
Bone Resorption
|
|
Concept
|
Carbolines
|
|
Concept
|
Chlorambucil
|
|
Concept
|
Chromosomes, Human
|
|
Concept
|
Chromosomes, Human, Pair 16
|
|
Concept
|
Consensus Development Conferences as Topic
|
|
Concept
|
DNA Restriction Enzymes
|
|
Concept
|
Monosomy
|
|
Concept
|
Oxides
|
|
Concept
|
Patient Compliance
|
|
Concept
|
Tumor Suppressor Protein p53
|
|
Concept
|
Oligonucleotides, Antisense
|
|
Concept
|
Cost of Illness
|
|
Concept
|
Computational Biology
|
|
Concept
|
Expressed Sequence Tags
|
|
Concept
|
Genomics
|
|
Concept
|
MicroRNAs
|
|
Concept
|
Medication Adherence
|
|
Academic Article
|
Rapid response of B-cell prolymphocytic leukemia to 2-chlorodeoxyadenosine.
|
|
Academic Article
|
Cytogenetic and molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases.
|
|
Academic Article
|
Clinical, morphologic, and cytogenetic characteristics of 26 patients with acute erythroblastic leukemia.
|
|
Academic Article
|
Polymerase chain reaction-based diagnosis of del (5q) in acute myeloid leukemia and myelodysplastic syndrome identifies a minimal deletion interval.
|
|
Academic Article
|
Cytogenetic and molecular delineation of a region of chromosome 7 commonly deleted in malignant myeloid diseases.
|
|
Academic Article
|
Successful treatment of angioimmunoblastic lymphadenopathy with dysproteinemia with fludarabine.
|
|
Academic Article
|
Clinical significance of the BCR-ABL fusion gene in adult acute lymphoblastic leukemia: a Cancer and Leukemia Group B Study (8762).
|
|
Academic Article
|
The capacity to be alone as a stress buffer.
|
|
Academic Article
|
Alteration of the proliferative rate of acute myelogenous leukemia cells in vivo in patients.
|
|
Academic Article
|
Familial myeloid leukemia associated with loss of the long arm of chromosome 5.
|
|
Academic Article
|
Myeloid leukemia after hematotoxins.
|
|
Academic Article
|
Clinical and cytogenetic responses to granulocyte-macrophage colony-stimulating factor in therapy-related myelodysplasia.
|
|
Academic Article
|
Phase I study of busulfan, cyclophosphamide, and timed sequential escalating doses of cytarabine followed by bone marrow transplantation.
|
|
Academic Article
|
Balanced translocations involving chromosome bands 11q23 and 21q22 in therapy-related leukemia.
|
|
Academic Article
|
High-energy total body irradiation as preparation for bone marrow transplantation in leukemia patients: treatment technique and related complications.
|
|
Academic Article
|
Refinement of the smallest commonly deleted segment of chromosome 20 in malignant myeloid diseases and development of a PAC-based physical and transcription map.
|
|
Academic Article
|
Molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases to 1-1.5 Mb and preparation of a PAC-based physical map.
|
|
Academic Article
|
Prevalence of the inactivating 609C-->T polymorphism in the NAD(P)H:quinone oxidoreductase (NQO1) gene in patients with primary and therapy-related myeloid leukemia.
|
|
Academic Article
|
Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukemia in first relapse.
|
|
Academic Article
|
A double-blind, placebo-controlled trial of pegylated recombinant human megakaryocyte growth and development factor as an adjunct to induction and consolidation therapy for patients with acute myeloid leukemia.
|
|
Academic Article
|
dic(5;17): a recurring abnormality in malignant myeloid disorders associated with mutations of TP53.
|
|
Academic Article
|
CBFA2(AML1) translocations with novel partner chromosomes in myeloid leukemias: association with prior therapy.
|
|
Academic Article
|
Detection of trisomy 12 in chronic lymphocytic leukemia by fluorescence in situ hybridization to interphase cells: a simple and sensitive method.
|
|
Academic Article
|
A prospective pilot study to evaluate a new dental assessment and treatment paradigm for patients scheduled to undergo intensive chemotherapy for cancer.
|
|
Academic Article
|
Cancer and Leukemia Group B (CALGB) studies in adult acute lymhocytic leukemia.
|
|
Academic Article
|
Impact of therapy With chlorambucil, fludarabine, or fludarabine plus chlorambucil on infections in patients with chronic lymphocytic leukemia: Intergroup Study Cancer and Leukemia Group B 9011.
|
|
Academic Article
|
Impact of azacytidine on the quality of life of patients with myelodysplastic syndrome treated in a randomized phase III trial: a Cancer and Leukemia Group B study.
|
|
Academic Article
|
A dose escalation study of total body irradiation followed by high-dose etoposide and allogeneic blood stem cell transplantation for the treatment of advanced hematologic malignancies.
|
|
Academic Article
|
Transcript map and comparative analysis of the 1.5-Mb commonly deleted segment of human 5q31 in malignant myeloid diseases with a del(5q).
|
|
Academic Article
|
New agents for induction and postremission therapy of acute myeloid leukemia.
|
|
Academic Article
|
Therapy-related myeloid leukemias are observed in patients with chronic lymphocytic leukemia after treatment with fludarabine and chlorambucil: results of an intergroup study, cancer and leukemia group B 9011.
|
|
Academic Article
|
Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia.
|
|
Academic Article
|
t(1;3)(p36;p21) is a recurring therapy-related translocation.
|
|
Academic Article
|
Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study.
|
|
Academic Article
|
Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B.
|
|
Academic Article
|
Acute lymphoblastic leukaemia: diagnosis and classification.
|
|
Academic Article
|
Lineage specific treatment of adult patients with acute lymphoblastic leukemia in first remission with anti-B4-blocked ricin or high-dose cytarabine: Cancer and Leukemia Group B Study 9311.
|
|
Academic Article
|
Polymorphisms in the MLL breakpoint cluster region (BCR).
|
|
Academic Article
|
Additional cytogenetic abnormalities in adults with Philadelphia chromosome-positive acute lymphoblastic leukaemia: a study of the Cancer and Leukaemia Group B.
|
|
Academic Article
|
P-glycoprotein (Pgp) modulation in untreated acute myeloid leukemia (AML): Cancer and Leukemia Group B (CALGB) trials in younger and older adults.
|
|
Academic Article
|
Abnormal cytogenetics at date of morphologic complete remission predicts short overall and disease-free survival, and higher relapse rate in adult acute myeloid leukemia: results from cancer and leukemia group B study 8461.
|
|
Academic Article
|
Phase 3 study of the multidrug resistance modulator PSC-833 in previously untreated patients 60 years of age and older with acute myeloid leukemia: Cancer and Leukemia Group B Study 9720.
|
|
Academic Article
|
Adult de novo acute myeloid leukemia with t(6;11)(q27;q23): results from Cancer and Leukemia Group B Study 8461 and review of the literature.
|
|
Academic Article
|
Repetitive cycles of high-dose cytarabine benefit patients with acute myeloid leukemia and inv(16)(p13q22) or t(16;16)(p13;q22): results from CALGB 8461.
|
|
Academic Article
|
Intensive chemotherapy with and without cranial radiation for Burkitt leukemia and lymphoma: final results of Cancer and Leukemia Group B Study 9251.
|
|
Academic Article
|
A phase I trial of gemcitabine plus cladribine in patients with advanced hematologic malignant diseases.
|
|
Academic Article
|
The U.S. trials in adult acute lymphoblastic leukemia.
|
|
Academic Article
|
Flavopiridol administered as a 24-hour continuous infusion in chronic lymphocytic leukemia lacks clinical activity.
|
|
Academic Article
|
Outcome of induction and postremission therapy in younger adults with acute myeloid leukemia with normal karyotype: a cancer and leukemia group B study.
|
|
Academic Article
|
Sequential multiagent chemotherapy is not superior to high-dose cytarabine alone as postremission intensification therapy for acute myeloid leukemia in adults under 60 years of age: Cancer and Leukemia Group B Study 9222.
|
|
Academic Article
|
Circulating immune complexes correlate with remission duration in acute myeloid leukemia.
|
|
Academic Article
|
Phase II trial of oral aminopterin for adults and children with refractory acute leukemia.
|
|
Academic Article
|
A retrospective study of 69 patients with t(6;9)(p23;q34) AML emphasizes the need for a prospective, multicenter initiative for rare 'poor prognosis' myeloid malignancies.
|
|
Academic Article
|
Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet.
|
|
Academic Article
|
Trisomy 6: a recurring cytogenetic abnormality associated with marrow hypoplasia.
|
|
Academic Article
|
Impact of disease burden at time of allogeneic stem cell transplantation in adults with acute myeloid leukemia and myelodysplastic syndromes.
|
|
Academic Article
|
Phase I study of oblimersen sodium, an antisense to Bcl-2, in untreated older patients with acute myeloid leukemia: pharmacokinetics, pharmacodynamics, and clinical activity.
|
|
Academic Article
|
Therapy-related myeloid leukaemia: a model for leukemogenesis in humans.
|
|
Academic Article
|
Myelodysplasia: when to treat and how.
|
|
Academic Article
|
Chronic lymphocytic leukemia masquerading as uveitis.
|
|
Academic Article
|
Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is active in patients with imatinib-resistant or -intolerant accelerated-phase chronic myelogenous leukemia.
|
|
Academic Article
|
Gene expression profiles in acute myeloid leukemia with common translocations using SAGE.
|
|
Academic Article
|
Nelarabine in the treatment of refractory T-cell malignant diseases.
|
|
Academic Article
|
Long-term disease-free survivors with cytogenetically normal acute myeloid leukemia and MLL partial tandem duplication: a Cancer and Leukemia Group B study.
|
|
Academic Article
|
Deletions of interferon genes in acute lymphoblastic leukemia.
|
|
Academic Article
|
Addition of rituximab to fludarabine may prolong progression-free survival and overall survival in patients with previously untreated chronic lymphocytic leukemia: an updated retrospective comparative analysis of CALGB 9712 and CALGB 9011.
|
|
Academic Article
|
Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia.
|
|
Academic Article
|
Continuous infusion mitoxantrone in relapsed acute nonlymphocytic leukemia.
|
|
Academic Article
|
Multiple unrelated clonal abnormalities in host bone marrow cells after allogeneic stem cell transplantation.
|
|
Academic Article
|
Some reasons for the lack of progress in the treatment of acute myelogenous leukemia: a review of three consecutive trials of the treatment of poor prognosis patients.
|
|
Academic Article
|
Dose escalation studies of cytarabine, daunorubicin, and etoposide with and without multidrug resistance modulation with PSC-833 in untreated adults with acute myeloid leukemia younger than 60 years: final induction results of Cancer and Leukemia Group B Study 9621.
|
|
Academic Article
|
An 86-probe-set gene-expression signature predicts survival in cytogenetically normal acute myeloid leukemia.
|
|
Academic Article
|
Clinical, morphologic, and cytogenetic characteristics of patients with lymphoid malignancies characterized by both t(14;18)(q32;q21) and t(8;14)(q24;q32) or t(8;22)(q24;q11).
|
|
Academic Article
|
Distinct microRNA expression profiles in acute myeloid leukemia with common translocations.
|
|
Academic Article
|
Irreversible myelosuppression after fludarabine-melphalan conditioning: observations in patients with graft rejection.
|
|
Academic Article
|
Prognostic significance of additional cytogenetic abnormalities in newly diagnosed patients with Philadelphia chromosome-positive chronic myelogenous leukemia treated with interferon-alpha: a Cancer and Leukemia Group B study.
|
|
Academic Article
|
Clinical efficacy of high-dose dexamethasone with maintenance dexamethasone/alpha interferon in patients with primary systemic amyloidosis: results of United States Intergroup Trial Southwest Oncology Group (SWOG) S9628.
|
|
Academic Article
|
Phase 1-2a multicenter dose-escalation study of ezatiostat hydrochloride liposomes for injection (Telintra, TLK199), a novel glutathione analog prodrug in patients with myelodysplastic syndrome.
|
|
Academic Article
|
Treatment of relapsed chronic lymphocytic leukemia by 72-hour continuous infusion or 1-hour bolus infusion of flavopiridol: results from Cancer and Leukemia Group B study 19805.
|
|
Academic Article
|
The t(2;5)(p23;q35): a recurring chromosomal abnormality in Ki-1-positive anaplastic large cell lymphoma.
|
|
Academic Article
|
Acute lymphoblastic leukemia: older patients and newer drugs.
|
|
Academic Article
|
Phase III study of PSC-833 (valspodar) in combination with vincristine, doxorubicin, and dexamethasone (valspodar/VAD) versus VAD alone in patients with recurring or refractory multiple myeloma (E1A95): a trial of the Eastern Cooperative Oncology Group.
|
|
Academic Article
|
Dasatinib induces significant hematologic and cytogenetic responses in patients with imatinib-resistant or -intolerant chronic myeloid leukemia in accelerated phase.
|
|
Academic Article
|
Nelarabine induces complete remissions in adults with relapsed or refractory T-lineage acute lymphoblastic leukemia or lymphoblastic lymphoma: Cancer and Leukemia Group B study 19801.
|
|
Academic Article
|
Clinicopathologic manifestations and breakpoints of the t(3;5) in patients with acute nonlymphocytic leukemia.
|
|
Academic Article
|
FLT3 D835/I836 mutations are associated with poor disease-free survival and a distinct gene-expression signature among younger adults with de novo cytogenetically normal acute myeloid leukemia lacking FLT3 internal tandem duplications.
|
|
Academic Article
|
Individual patient data meta-analysis of randomized trials evaluating IL-2 monotherapy as remission maintenance therapy in acute myeloid leukemia.
|
|
Academic Article
|
Low expression of MN1 associates with better treatment response in older patients with de novo cytogenetically normal acute myeloid leukemia.
|
|
Academic Article
|
Prognostic implications of morphology and karyotype in primary myelodysplastic syndromes.
|
|
Academic Article
|
Acute myelomonocytic leukemia with abnormal eosinophils and inv(16) or t(16;16) has a favorable prognosis.
|
|
Academic Article
|
High-dose cytosine arabinoside in the treatment of preleukemic disorders: a leukemia intergroup study.
|
|
Academic Article
|
A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811.
|
|
Academic Article
|
Rearrangements of the MLL gene in therapy-related acute myeloid leukemia in patients previously treated with agents targeting DNA-topoisomerase II.
|
|
Academic Article
|
Fludarabine followed by alemtuzumab consolidation for previously untreated chronic lymphocytic leukemia: final report of Cancer and Leukemia Group B study 19901.
|
|
Academic Article
|
A morphologic and cytochemical study of acute myelomonocytic leukemia with abnormal marrow eosinophils associated with inv(16)(p13q22).
|
|
Academic Article
|
Association of a chromosomal 3;21 translocation with the blast phase of chronic myelogenous leukemia.
|
|
Academic Article
|
Assignment of the GM-CSF, CSF-1, and FMS genes to human chromosome 5 provides evidence for linkage of a family of genes regulating hematopoiesis and for their involvement in the deletion (5q) in myeloid disorders.
|
|
Academic Article
|
Evidence for a 15;17 translocation in every patient with acute promyelocytic leukemia.
|
|
Academic Article
|
Neutrophil-assisted DNA synthesis by human lymphocytes in response to mevalonic acid; enhancement by cytochalasin B.
|
|
Academic Article
|
Der(5)t(5;7)(q11.2;p11.2): a new recurring abnormality in malignant myeloid disorders.
|
|
Academic Article
|
Acute myelomonocytic leukemia with abnormal eosinophils presenting as an ovarian mass: a report of two cases and a review of the literature.
|
|
Academic Article
|
Assignment of CSF-1 to 5q33.1: evidence for clustering of genes regulating hematopoiesis and for their involvement in the deletion of the long arm of chromosome 5 in myeloid disorders.
|
|
Academic Article
|
Short remission durations in therapy-related leukemia despite cytogenetic complete responses to high-dose cytarabine.
|
|
Academic Article
|
Management of myelodysplastic syndromes.
|
|
Academic Article
|
Chromosomal loss and deletion are the most common mechanisms for loss of heterozygosity from chromosomes 5 and 7 in malignant myeloid disorders.
|
|
Academic Article
|
Persistence of the 8;21 translocation in patients with acute myeloid leukemia type M2 in long-term remission.
|
|
Academic Article
|
Interleukin-4 and interleukin-5 map to human chromosome 5 in a region encoding growth factors and receptors and are deleted in myeloid leukemias with a del(5q).
|
|
Academic Article
|
Association of an inversion of chromosome 16 with abnormal marrow eosinophils in acute myelomonocytic leukemia. A unique cytogenetic-clinicopathological association.
|
|
Academic Article
|
Effective asparagine depletion with pegylated asparaginase results in improved outcomes in adult acute lymphoblastic leukemia: Cancer and Leukemia Group B Study 9511.
|
|
Academic Article
|
Blockade of miR-150 maturation by MLL-fusion/MYC/LIN-28 is required for MLL-associated leukemia.
|
|
Academic Article
|
Detection of MLL gene rearrangements in adult acute lymphoblastic leukemia. A Cancer and Leukemia Group B study.
|
|
Academic Article
|
Evidence for the involvement of GM-CSF and FMS in the deletion (5q) in myeloid disorders.
|
|
Academic Article
|
Dasatinib induces rapid hematologic and cytogenetic responses in adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia with resistance or intolerance to imatinib: interim results of a phase 2 study.
|
|
Academic Article
|
Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7.
|
|
Academic Article
|
Imatinib pharmacokinetics and its correlation with response and safety in chronic-phase chronic myeloid leukemia: a subanalysis of the IRIS study.
|
|
Academic Article
|
Response to 5-azacytidine in patients with refractory acute nonlymphocytic leukemia and association with chromosome findings.
|
|
Academic Article
|
Novel oncogenic mutations of CBL in human acute myeloid leukemia that activate growth and survival pathways depend on increased metabolism.
|
|
Academic Article
|
Cytogenetic clonality in myelodysplastic syndromes studied with fluorescence in situ hybridization: lineage, response to growth factor therapy, and clone expansion.
|
|
Academic Article
|
Chemoimmunotherapy with fludarabine and rituximab produces extended overall survival and progression-free survival in chronic lymphocytic leukemia: long-term follow-up of CALGB study 9712.
|
|
Academic Article
|
TET2 mutations improve the new European LeukemiaNet risk classification of acute myeloid leukemia: a Cancer and Leukemia Group B study.
|
|
Academic Article
|
Incidence of therapy-related myeloid neoplasia after initial therapy for chronic lymphocytic leukemia with fludarabine-cyclophosphamide versus fludarabine: long-term follow-up of US Intergroup Study E2997.
|
|
Academic Article
|
A recurring chromosome rearrangement, dic(16;22), in acute nonlymphocytic leukemia.
|
|
Academic Article
|
Chromosome changes in hematologic malignancies.
|
|
Academic Article
|
Establishment of a leukemia cell line with i(12p) from a patient with a mediastinal germ cell tumor and acute lymphoblastic leukemia.
|
|
Academic Article
|
A randomized controlled trial of filgrastim during remission induction and consolidation chemotherapy for adults with acute lymphoblastic leukemia: CALGB study 9111.
|
|
Academic Article
|
Risk factors for severe neuropsychiatric toxicity in patients receiving interferon alfa-2b and low-dose cytarabine for chronic myelogenous leukemia: analysis of Cancer and Leukemia Group B 9013.
|
|
Academic Article
|
Recent clinical trials in acute lymphocytic leukemia by the Cancer and Leukemia Group B.
|
|
Academic Article
|
Comparison of cytogenetic and molecular genetic detection of t(8;21) and inv(16) in a prospective series of adults with de novo acute myeloid leukemia: a Cancer and Leukemia Group B Study.
|
|
Academic Article
|
Genomic DNA breakpoints in AML1/RUNX1 and ETO cluster with topoisomerase II DNA cleavage and DNase I hypersensitive sites in t(8;21) leukemia.
|
|
Academic Article
|
Balanced chromosome abnormalities inv(16) and t(15;17) in therapy-related myelodysplastic syndromes and acute leukemia: report from an international workshop.
|
|
Academic Article
|
Isolated trisomy of chromosomes 8, 11, 13 and 21 is an adverse prognostic factor in adults with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B 8461.
|
|
Academic Article
|
Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461).
|
|
Academic Article
|
RAS, FLT3, and TP53 mutations in therapy-related myeloid malignancies with abnormalities of chromosomes 5 and 7.
|
|
Academic Article
|
Core binding factor acute myeloid leukemia. Cancer and Leukemia Group B (CALGB) Study 8461.
|
|
Academic Article
|
G3139, a BCL-2 antisense oligo-nucleotide, in AML.
|
|
Academic Article
|
Dose-ranging pharmacodynamic study of tipifarnib (R115777) in patients with relapsed and refractory hematologic malignancies.
|
|
Academic Article
|
Clofarabine in the treatment of acute myeloid leukaemia and acute lymphoblastic leukaemia: a review.
|
|
Academic Article
|
Select high-risk genetic features predict earlier progression following chemoimmunotherapy with fludarabine and rituximab in chronic lymphocytic leukemia: justification for risk-adapted therapy.
|
|
Academic Article
|
t(3;21)(q26;q22): a recurring chromosomal abnormality in therapy-related myelodysplastic syndrome and acute myeloid leukemia.
|
|
Academic Article
|
Allogeneic hematopoietic cell transplantation is not recommended for all adults with standard-risk acute lymphoblastic leukemia in first complete remission.
|
|
Academic Article
|
Influence of related donor age on outcomes after peripheral blood stem cell transplantation.
|
|
Academic Article
|
Fusion of the dominant negative transcription regulator CHOP with a novel gene FUS by translocation t(12;16) in malignant liposarcoma.
|
|
Academic Article
|
Leiomyosarcoma of the scrotum in a man who had received scrotal irradiation as a child.
|
|
Academic Article
|
Prediction of outcomes in patients with Ph+ chronic myeloid leukemia in chronic phase treated with nilotinib after imatinib resistance/intolerance.
|
|
Academic Article
|
A phase 3 study of gemtuzumab ozogamicin during induction and postconsolidation therapy in younger patients with acute myeloid leukemia.
|
|
Academic Article
|
Current practices in the management of chronic myeloid leukemia.
|
|
Academic Article
|
The spectrum of somatic mutations in high-risk acute myeloid leukaemia with -7/del(7q).
|
|
Academic Article
|
Phase II study of the oral MEK inhibitor selumetinib in advanced acute myelogenous leukemia: a University of Chicago phase II consortium trial.
|
|
Academic Article
|
A phase II study of the oral VEGF receptor tyrosine kinase inhibitor vatalanib (PTK787/ZK222584) in myelodysplastic syndrome: Cancer and Leukemia Group B study 10105 (Alliance).
|
|
Academic Article
|
Intensive induction is effective in selected octogenarian acute myeloid leukemia patients: prognostic significance of karyotype and selected molecular markers used in the European LeukemiaNet classification.
|
|
Academic Article
|
miR-155 expression is associated with chemoimmunotherapy outcome and is modulated by Bruton's tyrosine kinase inhibition with Ibrutinib.
|
|
Academic Article
|
Early molecular response predicts outcomes in patients with chronic myeloid leukemia in chronic phase treated with frontline nilotinib or imatinib.
|
|
Academic Article
|
The bone marrow niche, stem cells, and leukemia: impact of drugs, chemicals, and the environment.
|
|
Academic Article
|
Vatalanib population pharmacokinetics in patients with myelodysplastic syndrome: CALGB 10105 (Alliance).
|
|
Academic Article
|
Geriatric assessment to predict survival in older allogeneic hematopoietic cell transplantation recipients.
|
|
Academic Article
|
Arsenic trioxide in front-line therapy of acute promyelocytic leukemia (C9710): prognostic significance of FLT3 mutations and complex karyotype.
|
|
Academic Article
|
Oral Debio1143 (AT406), an antagonist of inhibitor of apoptosis proteins, combined with daunorubicin and cytarabine in patients with poor-risk acute myeloid leukemia--results of a phase I dose-escalation study.
|
|
Academic Article
|
Overexpression and knockout of miR-126 both promote leukemogenesis.
|
|
Academic Article
|
Inherited mutations in cancer susceptibility genes are common among survivors of breast cancer who develop therapy-related leukemia.
|
|
Academic Article
|
Transformation of chlorinated aliphatic compounds by ferruginous smectite.
|
|
Academic Article
|
Positron Emission Tomography-Computed Tomography Imaging of a Patient With Several Myeloid Sarcomas With FLT3-ITD and NPM1 Mutations.
|
|
Academic Article
|
Blinatumomab treatment of older adults with relapsed/refractory B-precursor acute lymphoblastic leukemia: Results from 2 phase 2 studies.
|
|
Academic Article
|
Incidence and predictors of respiratory viral infections by multiplex PCR in allogeneic hematopoietic cell transplant recipients 50 years and older including geriatric assessment.
|
|
Academic Article
|
Eradication of Acute Myeloid Leukemia with FLT3 Ligand-Targeted miR-150 Nanoparticles.
|
|
Academic Article
|
Telomere Length Recovery: A Strong Predictor of Overall Survival in Acute Promyelocytic Leukemia.
|
|
Academic Article
|
Determinants of fatal bleeding during induction therapy for acute promyelocytic leukemia in the ATRA era.
|
|
Academic Article
|
Nilotinib in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in blast crisis (CML-BC) who are resistant or intolerant to imatinib.
|
|
Academic Article
|
Nilotinib in accelerated phase chronic myelogenous leukemia (CML-AP) patients with imatinib-resistance or -intolerance: Update of a phase II study.
|
|
Academic Article
|
Phase I study of belinostat (PXD101) plus azacitidine (AZC) in patients with advanced myeloid neoplasms.
|
|
Academic Article
|
High incidence of FLT3 mutations in adults with Acute Promyelocytic Leukemia (APL): Correlation with diagnostic features and treatment outcome (CALGB 9710).
|
|
Academic Article
|
Managing CNS disease in adults with acute lymphoblastic leukemia.
|
|
Academic Article
|
Mechanisms of citral phototoxicity.
|
|
Academic Article
|
Pepsi® or Coke®? Influence of acid on dasatinib absorption.
|
|
Academic Article
|
Exposure-adjusted adverse events comparing blinatumomab with chemotherapy in advanced acute lymphoblastic leukemia.
|
|
Academic Article
|
A pediatric regimen for older adolescents and young adults with acute lymphoblastic leukemia: results of CALGB 10403.
|
|
Academic Article
|
Emerging Mutations at Relapse in Patients with FLT3-Mutated Relapsed/Refractory Acute Myeloid Leukemia Who Received Gilteritinib Therapy in the Phase 3 Admiral Trial.
|
|
Academic Article
|
Impact of NPM1/FLT3-ITD genotypes defined by the 2017 European LeukemiaNet in patients with acute myeloid leukemia.
|
|
Academic Article
|
Midostaurin in patients with acute myeloid leukemia and FLT3-TKD mutations: a subanalysis from the RATIFY trial.
|
|
Academic Article
|
Clonal evolution of acute myeloid leukemia with FLT3-ITD mutation under treatment with midostaurin.
|
|
Academic Article
|
Phase 3 randomized trial of chemotherapy with or without oblimersen in older AML patients: CALGB 10201 (Alliance).
|
|
Academic Article
|
Therapy-related myeloid neoplasms in 109 patients after radiation monotherapy.
|
|
Academic Article
|
Therapeutic drug monitoring in oncology: International Association of Therapeutic Drug Monitoring and Clinical Toxicology consensus guidelines for imatinib therapy.
|
|
Academic Article
|
Author Correction: Genome-wide association study identifies susceptibility loci for acute myeloid leukemia.
|
|
Academic Article
|
Follow-up of patients with R/R FLT3-mutation-positive AML treated with gilteritinib in the phase 3 ADMIRAL trial.
|
|
Academic Article
|
Enasidenib vs conventional care in older patients with late-stage mutant-IDH2 relapsed/refractory AML: a randomized phase 3 trial.
|
|
Academic Article
|
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data.
|
|
Academic Article
|
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN.
|
|
Academic Article
|
Molecular response in newly diagnosed chronic-phase chronic myeloid leukemia: prediction modeling and pathway analysis.
|
|
Concept
|
Bortezomib
|
|
Concept
|
Alpha-Ketoglutarate-Dependent Dioxygenase FTO
|
|
Concept
|
Ataxia Telangiectasia Mutated Proteins
|
|
Academic Article
|
Association of social deprivation with survival in younger adult patients with AML: an Alliance study.
|